TIAA-CREF Individual & Institutional Services’s Revolution Medicines RVMD Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.55M	Buy	+24,272	New	+$3.55M	0.02%	199

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's RVMD Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services opened a new position in Revolution Medicines (RVMD) in Q2 2026: 24,272 shares worth $4.55M. The stake represents 0.02% of the portfolio and ranks #199 among its holdings.

637 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

TIAA-CREF Individual & Institutional Services held 24,272 shares of Revolution Medicines worth $4.55M as of Q2 2026.
Revolution Medicines was a new TIAA-CREF Individual & Institutional Services position in Q2 2026.
Revolution Medicines made up 0.02% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #199 holding.
637 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.